Table 4: Fasting Laboratory and Other Characteristics of Female Patients with type 2 Diabetes Mellitus at 3 Months

Group A (n=19) Group B (n=30) p
Weight (kg) 72.6±19.9 75.3±13.9 ns
BMI (kg/m2) 28.5±7.4 31.1±4.9 ns
Waist circumference (cm) 100.9±17.2 104.9±12.1 ns
Body fat (%) 39.2±8.6 46.3±6.2 0.004
SBP (mmHg) 136.3±22.1 181.8±270.3 ns
DBP(mmHg) 75.5±13.8 77.3±12 ns
WCC (x103/µl) 6840±1693 7387±1515 ns
Uric acid (mg/dl) 4.9±1.3 5.6±1.3 ns
TC (mg/dl) 196±40 196±42 ns
TG (mg/dl) 125±57 168±94 ns
HDL-C (mg/dl) 65±18 50±12 0.001
LDL-C (mg/dl) 106±34 113±30 ns
AST (u/l) 23±10 20±6 ns
ALT(u/l) 25±15 22±9 ns
CK (u/l) 83±34 97±73 ns
Gamma-GT (u/l) 15
(7-292)
16
(10-79)
ns
Glucose (mg/dl) 141±50 141±34 ns
HbA1c (%) 7.2±1.4 6.2±0.8 N/A
Cr (mg/dl) 0.8±0.2 0.8±0.2 ns
Leptin (ng/ml) 23.4±13.5 20.2±10.9 ns
Adiponectin (µg/ml) 12.9±11.5 11.3±5.3 ns
Ghrelin (pg/ml) 907±284 836±315 ns
NPY (pmol/L) 118.9±22.9 137.4±43.8 ns
MDRD eGFR (mL/min/1.73m2) 88.3±25.9 87.9±31.4 ns
Cockroft-Gault creatinine clearance (mL/min) 95.7±48.3 94.1±36.2 ns

For abbreviations see Table 1.